Applications of iPSC Gene Editing Technologies in Biomedical Research | Promotions

Abstract

Human induced pluripotent stem cells (iPSCs) are a cornerstone of in vitro disease modeling, drug discovery, and cell-based therapeutic strategies. Leveraging the power of gene editing technologies, the precise correction of pathogenic gene mutations in patient-derived iPSCs for therapeutic intervention represents a critical frontier in translational and regenerative medicine research. However, realizing the full potential of iPSCs necessitates addressing inherent challenges, including suboptimal induction efficiency, demanding culture and expansion protocols, and complexities in clinical translation.

This webinar will explore strategic approaches to enhance preclinical research efficacy and streamline downstream translational applications across diverse scenarios, encompassing functional genomics, drug development, regenerative medicine, and stem cell therapy. Furthermore, it will address specific gene editing hurdles encountered in iPSC research, notably differentiation-associated loss of pluripotency and the intricacies of monoclonal selection.

Meet the Speaker

Lily Fan
Cell and Gene Editing Platform Manager, Cyagen

With over 9 years of experience in stem cell research and gene editing. Lily Fan specializes in iPSC reprogramming, gene editing technologies, cell differentiation, and in vitro screening platforms. Previously, Lily Fan managed projects at Genscript, leading multiple initiatives integrating molecular and cellular biology techniques.

Who Should Attend

Stem cell researchers and scientists working with iPSCs
Molecular biologists and geneticists interested in gene editing applications
Drug discovery and development professionals focusing on disease modeling
Translational medicine researchers and regenerative therapy developers
Graduate students and postdoctoral fellows specializing in stem cell biology and biopharmaceutical development

Recommended Background

Stem cell engineering
Rare disease modeling
Biopharmaceutical development
Regenerative medicine
Molecular biology
Genetics
Biotechnology
Life Science

What You’ll Learn

The current applications of gene-edited iPSCs in functional genomics, drug development, regenerative medicine, and stem cell therapy
Key challenges in iPSC gene editing, including low induction efficiency and maintaining pluripotency during differentiation
Strategies to overcome difficulties in iPSC culture, expansion, and monoclonal selection
Approaches to enhance preclinical research efficiency and facilitate translational and clinical applications of gene-edited iPSCs

Webinar Details

Date: May 29, 2025
Time: 9:00 AM (PDT) | 12:00 PM (EDT) | 6:00 PM (CET)
Format: Live Webinar (with Q&A)
Language: English
Duration: ~30 mins + 10 mins Q&A

Registration

Reserve Your Spot Now

➔ Secure access to exclusive technical insights

➔ Live Q&A: Directly engage with field pioneers

➔ Post-webinar resource kit: Protocols and case studies

Download Related Resources

Looking to advance your research beyond the webinar? Explore our featured services supporting gene editing and iPSC-based modeling:

1. Custom Cell Line Services
Build precise gene-edited cell models tailored to your research — including KO/KI, overexpression, and reporter lines.
[Download Flyer]

2. iPSC Disease Models
Explore disease-relevant iPSC models with full support for reprogramming, editing, and differentiation.
[Download Flyer]